TOP TIERMARKET NEWSWIRE
News & sentiment

ATRIUM THERAPEUTICS (RNA) — News & AI sentiment

ATRIUM THERAPEUTICS (RNA) news roundup. 2 stories in the past week, 23 over 30 days. Average 30-day sentiment is 48.6/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 56.5/100
30d stories
23
avg sentiment 48.6/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

RNA news in the last 24 hours, 7 days, 30 days and 90 days

How much RNA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowRNA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days256.5/100RNA headlines →
Last 30 days2348.6/100RNA headlines →
Last 90 days3752/100RNA headlines →

Latest stories on RNA

4d ago
4d ago
Oct 28
Oct 27
Oct 27
Oct 27
Oct 22
Roth/MKM initiates Atrium Therapeutics stock with buy rating
Investing.com Analyst Ratings63 · neutralanalyst
Oct 22
Oct 21
Oct 20
Oct 20
Oct 20
Cantor Fitzgerald reiterates Atrium Therapeutics stock Overweight
Investing.com Analyst Ratings61 · neutralanalyst
Oct 15
Oct 9
Oct 9
Oct 8
Why is Atrium Therapeutics stock surging today?
Investing.com Markets64 · neutralgeneral
Oct 8
Oct 8
Oct 8
Oct 8
Oct 8
Oct 8
Oct 7
Sep 27
Sep 21
Open RNA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →